Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

NCT00761202 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE®
DRUG: Sodium hyaluronate

Sponsor

Allergan